WUXI BIOLOGICS CAYMAN INC USD0000025 144A REG S ISIN KYG9700's ticker is and the CUSIP is G97008109. A total of 1 filers reported holding WUXI BIOLOGICS CAYMAN INC USD0000025 144A REG S ISIN KYG9700 in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $74,783,000 | +32.4% | 3,073,012 | -0.4% | 0.46% | +4.3% |
| Q2 2020 | $56,464,000 | +99.2% | 3,086,203 | +41.2% | 0.44% | +30.0% |
| Q1 2020 | $28,340,000 | +54.4% | 2,185,656 | +50.8% | 0.34% | +78.9% |
| Q4 2019 | $18,350,000 | +19.2% | 1,449,371 | -3.9% | 0.19% | +7.3% |
| Q3 2019 | $15,395,000 | +12.0% | 1,508,620 | -1.4% | 0.18% | +27.3% |
| Q2 2019 | $13,742,000 | -3.7% | 1,530,449 | +4.3% | 0.14% | -8.6% |
| Q1 2019 | $14,267,000 | – | 1,466,856 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GILDER GAGNON HOWE & CO LLC | 3,086,203 | $56,464,000 | 0.44% |